Professor and Course Leader Implant Dentistry at the College of Medicine & Dentistry (Birmingham, University of Ulster, UK). 1992: DDS, 1996: PhD, 1997: MS Peridontology and 2016: MClinDent. Published more then 40 articles in international dental journals. Co-author of 8 books/chapters in books. Editor in chief of the Journal of Dental Health, Oral Disorders & Therapy and of the Journal of Dental Reports. International referent and lecturer on ceramic dental implants, short dental implants, concentrated growth factors and halitosis. Leads a clinic in the Netherlands, limited to periodontology, implant dentistry and halitosis. Practitioner of ceramic implant dentistry since 2009. European Academy for Ceramic Implantology -ambassador for the UK & NL since 2020.
Jim is a founder, investor, and current CEO of Rowpar Pharmaceuticals. He led the Company in its transition from exclusive sales to dental professionals to distribution through mass retailers, such as Amazon, CVS and Walgreen’s pharmacies, and Walmart. Jim also led in the research and development of 2nd and 3rd generation ClōSYS products and the intellectual property supporting them. Accompanying these changes, Jim led in the development of a professional management teach and a professional Board of Directors where individual members reflect the key areas of Rowpar’s business.
Patrick Fellus, MD specializes in dentofacial orthopedics. He serves as the President of the French Pediatric Orthodontic Society, and works at the University Hospital Robert Debré in Paris. Former legal expert in France. He published several peer reviewed articles on various subjects including orofacial myofuntional disorders in French journals.